249 related articles for article (PubMed ID: 31205555)
21. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E
Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748
[TBL] [Abstract][Full Text] [Related]
22. Exosomal miR-200c and miR-141 as cerebrospinal fluid biopsy biomarkers for the response to chemotherapy in primary central nervous system lymphoma.
Hu Y; Zhang Q; Wu Z; Chen K; Xu X; Ma W; Chen B; Jin L; Guan M
Discov Oncol; 2023 Nov; 14(1):205. PubMed ID: 37971595
[TBL] [Abstract][Full Text] [Related]
23. Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts.
Savolainen K; Scaravilli M; Ilvesmäki A; Staff S; Tolonen T; Mäenpää JU; Visakorpi T; Auranen A
BMC Res Notes; 2020 Jul; 13(1):311. PubMed ID: 32611374
[TBL] [Abstract][Full Text] [Related]
24. A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules.
Liang M; Yu S; Tang S; Bai L; Cheng J; Gu Y; Li S; Zheng X; Duan L; Wang L; Zhang Y; Huang X
Front Genet; 2020; 11():449. PubMed ID: 32508877
[No Abstract] [Full Text] [Related]
25. Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer.
Kumar V; Gupta S; Chaurasia A; Sachan M
Front Oncol; 2021; 11():681872. PubMed ID: 34692473
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
[TBL] [Abstract][Full Text] [Related]
27. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
28. Tissue and Circulating MicroRNA-31, MicroRNA-200b, and MicroRNA-200c Reflects Disease Activity in Crohn's Disease Patients: Results from the BIOMIR Study.
Tocia C; Dumitru A; Mateescu B; Negreanu L; State M; Cozaru GC; Mitroi AF; Brinzan C; Popescu R; Leopa N; Iordache MM; Manea M; Matei E; Dumitru E; Alexandrescu L
J Gastrointestin Liver Dis; 2023 Mar; 32(1):30-38. PubMed ID: 37004230
[TBL] [Abstract][Full Text] [Related]
29. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
30. Isolation and quantification of microRNAs from urinary exosomes/microvesicles for biomarker discovery.
Lv LL; Cao Y; Liu D; Xu M; Liu H; Tang RN; Ma KL; Liu BC
Int J Biol Sci; 2013; 9(10):1021-31. PubMed ID: 24250247
[TBL] [Abstract][Full Text] [Related]
31. The circulating microRNA-200 family in whole blood are potential biomarkers for high-grade serous epithelial ovarian cancer.
Pendlebury A; Hannan NJ; Binder N; Beard S; Mcgauran M; Grant P; Tong S; Whitehead CL
Biomed Rep; 2017 Mar; 6(3):319-322. PubMed ID: 28451393
[TBL] [Abstract][Full Text] [Related]
32. Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis.
Liu Y; Tang J; Qiu X; Teng LA; Sriwastva MK; Han X; Li Z; Liu M; Liu S; Da D; Li Z; Zhen L; Ren Y
Breast Cancer (Dove Med Press); 2023; 15():403-419. PubMed ID: 37274058
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.
Ibrahim FF; Jamal R; Syafruddin SE; Ab Mutalib NS; Saidin S; MdZin RR; Hossain Mollah MM; Mokhtar NM
J Ovarian Res; 2015 Aug; 8():56. PubMed ID: 26260454
[TBL] [Abstract][Full Text] [Related]
34. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.
Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K
Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595
[TBL] [Abstract][Full Text] [Related]
35. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
[TBL] [Abstract][Full Text] [Related]
36. Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts.
Todeschini P; Salviato E; Paracchini L; Ferracin M; Petrillo M; Zanotti L; Tognon G; Gambino A; Calura E; Caratti G; Martini P; Beltrame L; Maragoni L; Gallo D; Odicino FE; Sartori E; Scambia G; Negrini M; Ravaggi A; D'Incalci M; Marchini S; Bignotti E; Romualdi C
Cancer Lett; 2017 Mar; 388():320-327. PubMed ID: 28017893
[TBL] [Abstract][Full Text] [Related]
37. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing.
Zhang H; Xu S; Liu X
Oncol Lett; 2019 Jun; 17(6):5601-5607. PubMed ID: 31186782
[TBL] [Abstract][Full Text] [Related]
39. miR-200b and miR-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases.
Liu J; Zhang X; Huang Y; Zhang Q; Zhou J; Zhang X; Wang X
Oncol Lett; 2019 Feb; 17(2):1453-1460. PubMed ID: 30675199
[TBL] [Abstract][Full Text] [Related]
40. Circulating Exosomal miR-150-5p and miR-99b-5p as Diagnostic Biomarkers for Colorectal Cancer.
Zhao YJ; Song X; Niu L; Tang Y; Song X; Xie L
Front Oncol; 2019; 9():1129. PubMed ID: 31750241
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
